Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Guidelines for diagnosing common hair loss include detailed history, clinical examination, and various diagnostic techniques.

"Male-pattern" hair loss is common in women, especially after menopause, and doesn't always mean there's a problem with hormone balance.

Women with PCOS have more body fat and thicker fat layers in certain abdominal areas than women without PCOS.

S5αR inhibitors might help treat schizophrenia and other mental disorders but need more research.

Women with PCOS have fewer activated T cells in their ovarian follicles, which might affect fertility.

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.

Alopecia areata involves immune system imbalances that may lead to depression and anxiety.

Certain microRNAs in the fluid around eggs are linked to Polycystic Ovary Syndrome and may help diagnose it.

These drugs cause hair growth without affecting testosterone or adrenal hormones.

Male pattern baldness may be caused by scalp pressure on hair follicles, which increases with age and leads to a cycle of hair loss. This process is not directly determined by genes.

Men with male-pattern baldness have higher levels of certain testosterone metabolites and may have more active androgen metabolism.

t-Flavanone may help hair growth by reducing a specific protein's activity in skin cells.

Janus kinase inhibitors show promise in treating alopecia areata but need more safety research.

A possible link exists between minimal change nephrotic syndrome and complete hair loss.

Fenugreek seed extract boosts testosterone and improves male reproductive health without heart side effects.

Lenalidomide helps hair follicle stem cells turn into melanocytes, which may improve repigmentation in vitiligo.

The document concludes that Cutaneous Lupus Erythematosus has different forms, is influenced by genetic and environmental factors, and can be treated with various medications, but more targeted therapies are needed.

Alopecia areata is an autoimmune disease affecting hair follicles and may harm heart health.

Women with PCOS are more likely to have fatty liver disease and worse metabolic health.

Blocking IL-17 signaling may reduce skin inflammation and delay aging.

New treatments for enlarged prostate are being developed, some of which may be more effective than current medications.

The document concludes that computational models are useful for understanding immune responses and could improve cancer immunotherapy.

Ganoderma lucidum may help treat prostate cancer by blocking male hormones and slowing cancer cell growth.

Women with a certain type of tumor had higher levels of pregnancy hormone and male hormones, which decreased after treatment.

Animal models have helped understand hair loss from alopecia areata and find new treatments.

Avicennia marina extract and avicequinone C can potentially promote hair growth and treat hair loss by interfering with hair loss mechanisms and boosting growth factors.

Lifestyle changes can improve body composition, excess male hormone levels, and insulin resistance in women with PCOS.

Hormone treatments in transsexual individuals reduce hair growth and oil production in male-to-females and increase them in female-to-males.

Transplant success has improved with better immunosuppressive drugs and donor matching.

JAK inhibitors help with skin conditions but need more research on dosing and safety.